Lääkealan turvallisuus- ja kehittämiskeskus Fimea - Selaus tekijän mukaan "et. al."
Viitteet 1-3 / 3
-
2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines ‘Scientific’? : Part 1 – LCMS: small molecules, peptides and small molecule biomarkers
Bioanalysis : 22 (Future Science, 17.11.2017)The 2017 11th Workshop on Recent Issues in Bioanalysis (11th WRIB) took place in Los Angeles/Universal City, California on 3–7 April 2017 with participation of close to 750 professionals from pharmaceutical/biopharmaceutical ... -
2017 White Paper on recent issues in bioanalysis: rise of hybrid LBA/LCMS immunogenicity assays : Part 3 – LBA: immunogenicity, biomarkers and PK assays
Bioanalysis : 9 (Future Science, 05.12.2017)The 2017 11th Workshop on Recent Issues in Bioanalysis (11th WRIB) took place in Los Angeles/Universal City, California on 3–7 April 2017 with participation of close to 750 professionals from pharmaceutical/biopharmaceutical ... -
Commentary on the MID3 good practices paper
CPT : Pharmacometrics and Systems Pharmacology : 7 (American Society for Clinical Pharmacology and Therapeutics, 07 / 2017)During the last 10 years the European Medicines Agency (EMA) organized a number of workshops on modeling and simulation, working towards greater integration of modeling and simulation (M&S) in the development and regulatory ...
